CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Clinical trial NCT06667050 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06667050
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2026-10-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.